Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives

SIMPLE SUMMARY: Immune checkpoint inhibitors represent a promising treatment choice in many kind of tumours, including hepatocellular carcinoma (HCC). In this review, we provide an overview of the role of these new agents in the management of HCC according to the Barcelona staging system, alongside...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Federico, Piera, Petrillo, Angelica, Giordano, Pasqualina, Bosso, Davide, Fabbrocini, Antonietta, Ottaviano, Margaret, Rosanova, Mario, Silvestri, Antonia, Tufo, Andrea, Cozzolino, Antonio, Daniele, Bruno
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7603151/
https://ncbi.nlm.nih.gov/pubmed/33080958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12103025
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados